Saturday 17 October 2026
Export DFTX’s income statement to Excel — free account
Definium Therapeutics, Inc.
DFTX Healthcare Biotechnology
In the quarter to June 2026, EPS fell 188.0%, free cash flow fell 78.3% and total debt fell 11.5%, each against the same quarter a year earlier.
32.10
2.16
−6.30%
Follow DFTX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
6.29 | 7.25 | 3.22 | 8.16 | 13.18 | 27.10 | 14.76 | 24.22 | 22.04 | 1.80 |
Net Debt/EBITDA |
2.21 | 2.44 | 0.94 | 2.25 | 1.46 | 2.42 | 0.00 | 0.18 | 1.36 | 0.00 |
Debt/Assets |
9.22% | 7.23% | 11.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.12 | 0.09 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.72 | 0.73 | 0.67 | 0.88 | 0.49 | 0.70 | 0.30 | 0.84 | 0.54 | 0.15 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Interest Coverage |
(30.34) | (45.52) | (102.03) | (59.90) | (261.43) | (201.40) | 1,072.70 | (430.95) | 0.00 | (185.50) |
| (64.06%) | (68.01%) | (83.59%) | (37.54%) | (81.78%) | (87.05%) | (455.48%) | (21.94%) | (60.35%) | (8.20%) | |
| (49.52%) | (50.94%) | (65.01%) | (34.01%) | (75.79%) | (80.69%) | (823.70%) | (45.91%) | (1,306.54%) | (7.90%) | |
ROIC |
0.00% | 0.00% | 0.00% | (472.44%) | (323.63%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(52.12%) | (44.77%) | (133.66%) | (44.32%) | (73.37%) | (43.23%) | (508.01%) | (337.36%) | (69.62%) | (296.38%) |
Average Days of Receivables |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.05 | 0.07 | 0.16 | 0.14 | 0.16 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Free Cash Flow per Share |
(1.47) | (1.12) | (1.64) | (1.62) | (1.67) | (1.33) | (0.47) | (1.70) | (2.11) | (0.02) |
Cash per Share |
4.61 | 3.89 | 2.55 | 4.61 | 4.88 | 4.51 | 0.00 | 0.36 | 5.35 | 0.08 |
Shareholders Equity per Share |
3.72 | 3.43 | 2.00 | 4.89 | 5.54 | 4.27 | 0.00 | 8.29 | 12.49 | 0.08 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.72 | 3.43 | 2.00 | 4.89 | 5.54 | 4.27 | 0.00 | 8.29 | 12.49 | 0.08 |
Free Cash Flow |
(131.56) | (79.13) | (64.36) | (50.14) | (45.82) | (23.60) | (3.20) | (0.53) | (0.53) | (0.02) |
Working Capital |
352.62 | 242.77 | 71.63 | 128.16 | 126.81 | 78.51 | 2.11 | 0.14 | 1.35 | 0.04 |
Capital Expenditures |
— | — | — | — | — | — | (0.24) | (0.77) | (1.72) | (0.02) |
Net Current Asset Value |
311.55 | 220.92 | 57.47 | 126.98 | 124.88 | 75.87 | 2.26 | 0.14 | 1.35 | 0.04 |
| Other line items | ||||||||||
Quick Ratio |
6.17 | 7.05 | 3.09 | 7.94 | 12.83 | 26.63 | 0.09 | 19.88 | 21.16 | 1.78 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.08 | — |
Cash ROIC |
(16.77%) | (14.73%) | (33.53%) | (17.11%) | (16.07%) | (15.13%) | (23,232.96%) | (19.64%) | (11.78%) | (10.37%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.47) | (1.12) | (1.64) | (1.62) | (1.67) | (1.33) | (0.47) | (1.70) | (2.11) | (0.02) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | — | 0.00 | 0.01 | 0.01 | 0.01 |
Average Payables |
3.68 | 3.07 | 3.12 | 3.14 | 3.10 | 3.10 | — | — | — | — |
Average Assets |
371.13 | 213.35 | 147.27 | 167.00 | 122.76 | 42.06 | 1.30 | 1.37 | 0.08 | 1.69 |
Average Common Equity |
286.89 | 159.79 | 114.53 | 151.29 | 113.77 | 38.99 | 2.35 | 2.87 | 1.63 | 1.63 |
Columns are period end dates